BRPI0923279A2 - formas cristalinas do composto 2-[4-(7-etil-5h-pirrol[2,3-b]pirazin-6-il)-fenil]-propan-2-ol, seu uso e processo de obtenção - Google Patents

formas cristalinas do composto 2-[4-(7-etil-5h-pirrol[2,3-b]pirazin-6-il)-fenil]-propan-2-ol, seu uso e processo de obtenção

Info

Publication number
BRPI0923279A2
BRPI0923279A2 BRPI0923279A BRPI0923279A BRPI0923279A2 BR PI0923279 A2 BRPI0923279 A2 BR PI0923279A2 BR PI0923279 A BRPI0923279 A BR PI0923279A BR PI0923279 A BRPI0923279 A BR PI0923279A BR PI0923279 A2 BRPI0923279 A2 BR PI0923279A2
Authority
BR
Brazil
Prior art keywords
pyrazin
pyrrol
propan
phenyl
ethyl
Prior art date
Application number
BRPI0923279A
Other languages
English (en)
Inventor
Beverly C Langevin
Daniel Sherer
Elizabeth Secord
George Logue
Kenneth J Bordeau
Patricia Logue
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of BRPI0923279A2 publication Critical patent/BRPI0923279A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BRPI0923279A 2008-12-04 2009-12-03 formas cristalinas do composto 2-[4-(7-etil-5h-pirrol[2,3-b]pirazin-6-il)-fenil]-propan-2-ol, seu uso e processo de obtenção BRPI0923279A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11986608P 2008-12-04 2008-12-04
PCT/US2009/066489 WO2010065690A1 (en) 2008-12-04 2009-12-03 Crystalline forms

Publications (1)

Publication Number Publication Date
BRPI0923279A2 true BRPI0923279A2 (pt) 2016-01-26

Family

ID=42109934

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0923279A BRPI0923279A2 (pt) 2008-12-04 2009-12-03 formas cristalinas do composto 2-[4-(7-etil-5h-pirrol[2,3-b]pirazin-6-il)-fenil]-propan-2-ol, seu uso e processo de obtenção

Country Status (15)

Country Link
US (1) US20110257190A1 (pt)
EP (1) EP2373655A1 (pt)
JP (1) JP2012511005A (pt)
KR (1) KR20110108334A (pt)
CN (1) CN102239169A (pt)
AR (1) AR074538A1 (pt)
AU (1) AU2009322409A1 (pt)
BR (1) BRPI0923279A2 (pt)
CA (1) CA2745262A1 (pt)
IL (1) IL213288A0 (pt)
MX (1) MX2011004793A (pt)
RU (1) RU2011127147A (pt)
TW (1) TW201033211A (pt)
UY (1) UY32293A (pt)
WO (1) WO2010065690A1 (pt)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1221918E (pt) 1999-10-21 2005-06-30 Alcon Inc Administracao de drogas sub-tenon
US20050059639A1 (en) 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
CL2007002617A1 (es) 2006-09-11 2008-05-16 Sanofi Aventis Compuestos derivados de pirrolo[2,3-b]pirazin-6-ilo; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar inflamacion de las articulaciones, artritis reumatoide, tumores, linfoma de las celulas del manto.

Also Published As

Publication number Publication date
JP2012511005A (ja) 2012-05-17
IL213288A0 (en) 2011-07-31
AU2009322409A1 (en) 2011-06-23
US20110257190A1 (en) 2011-10-20
EP2373655A1 (en) 2011-10-12
AR074538A1 (es) 2011-01-26
RU2011127147A (ru) 2013-01-10
KR20110108334A (ko) 2011-10-05
CN102239169A (zh) 2011-11-09
WO2010065690A1 (en) 2010-06-10
CA2745262A1 (en) 2010-06-10
TW201033211A (en) 2010-09-16
MX2011004793A (es) 2011-05-30
UY32293A (es) 2010-07-30

Similar Documents

Publication Publication Date Title
BRPI0916110A2 (pt) "processo para preparação do co-precipitado, co-precipitado e kit para preparar um implante osteogênico"
BRPI0918972A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso
BRPI0905910A2 (pt) Método para fabricar materiais mesoporosos, materiais assim produzidos e uso de materiais mesoporosos.
BRPI0920812A2 (pt) processo para a preparação de policondensados fosfatados e uso dos mesmos
BRPI0924622A2 (pt) composições para tratamento de tecidos, processo de fabricação, e método de uso.
BRPI1011384A2 (pt) pro-proteinas e seus metodos de uso
BRPI1009481A2 (pt) compostos de 2-acetamido-5-aril-1,2,4-triazolonas substituídas, seu processo de preparação, seu uso e medicamento compreendendo os mesmos
BRPI0908268A2 (pt) compostos do inibidor de raf e seus métodos de uso
BRPI0918694A2 (pt) processo de detecção de coliforme e kit para uso do mesmo
BRPI0924183A2 (pt) inibidores de proteína quinase, formas cristalinas, formulações farmacêuticas e uso
DK3309139T3 (da) Process for the preparation of 2,3,3,3-trifluoropropene
BRPI0919018A2 (pt) sal farmaceuticamente aceitável, uso de sal, e, processo para a preparação de sal
CL2013001723A1 (es) Formas cristalinas de 5-cloro-n2-(2-isopropoxi-5-metil-4-piperidin-4-il-fenil)-n4-[2-(propan-2-sulfonil)-fenil]-pirimidin-2,4-diamina; metodos de preparacion; composicion farmaceutica; y el uso en el tratamiento de los trastornos mediados por la cinasa de linfoma anaplasico.
BRPI0808106A2 (pt) Núcleo absorvente, artigo absorvente descartável e método para fabricação dos mesmos
BRPI0908252A2 (pt) Processo para preparar um composto, e, uso de um composto
BRPI0817270A2 (pt) formas sólidas de 2-amino-3-(4-(2-amino-6((r)-1-1(4-cloro-2-(3-metil-1h-pirazol-1-il)) fenil-2,2,2-triflúor etóxi) pirimidin-4-il) fenil) propanoato de (s)-etila e processos de seu uso
BRPI0921546A2 (pt) Compostos de arilazol-2-il cianoetilamina enriquecidos enantiomericamente, método para fabricação e método de uso dos mesmos
SMT201500095B (it) Forme cristalline di sale cloridrato di (4A-R, 9A-S)-1-(1hbenzoimidazolo-5-carbonil)-2,3,4,4A,9,9A-esaidro-1H-indeno[2,1-B]piridin-6-carbonitrile e loro uso come inibitore della hsd1
SMT201300063B (it) Procedimento per preparazione di composti piperazinici e loro sali idrocloruri
BRPI0811826A2 (pt) ''uso de composto organosfosforado, artigo e processo de fabricação de um artigo
BRPI0918487A2 (pt) processo para a preparação de uma composição de copolímero, composição, e, uso de uma composição de copolímero
EP2278298A4 (en) Quartz oscillator and measurement method using same
CL2007003830A1 (es) Formas cristalinas a, b, y c, forma amorfa y forma co-cristalina de [4-(3-fluor-5-trifluormetil-piridin-2-il)-piperazin-1-il]-[5-metanosulfonil-2-((s)-2,2,2-trifluor-1-metil-etoxi)-fenil]-metanona; metodos de preparacion; composicion farmaceutica; y
BRPI1010764A2 (pt) "sais de derivados de pirazolon-azo biciclo substituído, método de preparação e uso do mesmo"
BRPI0818350A2 (pt) formas sólidas de ácido (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-triflúor-1-(3-metoxibifenil-4-il)etóxi)pirimidin-4-il)fenil)propanoico e processo para uso das mesmas

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]